相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Ubiquity: a framework for physiological/mechanism-based pharmacokinetic/pharmacodynamic model development and deployment
John M. Harrold et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
Miroslav Dostalek et al.
CLINICAL PHARMACOKINETICS (2013)
Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development
P. A. Milligan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Issues, Challenges, and Opportunities in Model-Based Drug Development for Monoclonal Antibodies
Leijun Hu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Antibody biodistribution coefficients Inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human
Dhaval K. Shah et al.
MABS (2013)
Local versus Systemic Anti-Tumour Necrosis Factor-α Effects of Adalimumab in Rheumatoid Arthritis Pharmacokinetic Modelling Analysis of Interaction between a Soluble Target and a Drug
David Stepensky
CLINICAL PHARMACOKINETICS (2012)
Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human
Dhaval K. Shah et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer
Lubna Abuqayyas et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
Smarter Drugs A Focus on Pan-Specific Monoclonal Antibodies
Severine Fagete et al.
BIODRUGS (2011)
Buy buy bispecific antibodies
David Holmes
NATURE REVIEWS DRUG DISCOVERY (2011)
Treatment of allergic asthma: Modulation of Th2 cells and their responses
Berislav Bosnjak et al.
RESPIRATORY RESEARCH (2011)
Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Concepts and Lessons for Drug Development
Diane R. Mould et al.
BIODRUGS (2010)
Airway Wall Expression of OX40/OX40L and Interleukin-4 in Asthma
Salman Siddiqui et al.
CHEST (2010)
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
Nathanael L. Dirks et al.
CLINICAL PHARMACOKINETICS (2010)
Biodistribution of [125I]-Labeled Therapeutic Proteins: Application in Protein Drug Development Beyond Oncology
Yulia Vugmeyster et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Physiologically Based Pharmacokinetic Model for T84.66: A Monoclonal Anti-CEA Antibody
Shweta R. Urva et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Target-mediated drug disposition model for drugs that bind to more than one target
Leonid Gibiansky et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2010)
Serum BLC/CXCL13 Concentrations and Renal Expression of CXCL13/CXCR5 in Patients with Systemic Lupus Erythematosus and Lupus Nephritis
Hui-Ting Lee et al.
JOURNAL OF RHEUMATOLOGY (2010)
Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma
C. K. Oh et al.
EUROPEAN RESPIRATORY REVIEW (2010)
The affinity of human RANK binding to its ligand RANKL
Shiqian Zhang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
Bispecific T-Cell Engaging Antibodies for Cancer Therapy
Patrick A. Baeuerle et al.
CANCER RESEARCH (2009)
Defining dose-response relationships in the therapeutic blockade of B7RP-1-dependent immune responses
Daniela P. Metz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus
M. Her et al.
LUPUS (2009)
B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE)
Lena Schiffer et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
Jenny Bostrom et al.
SCIENCE (2009)
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
W. Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Untangling the Complex Web of IL-4-and IL-13-Mediated Signaling Pathways
Marsha Wills-Karp et al.
SCIENCE SIGNALING (2008)
Differences in expression, affinity, and function of soluble (s)IL-4Rα and sIL-13Rα2 suggest opposite effects on allergic responses
Marat Khodoun et al.
JOURNAL OF IMMUNOLOGY (2007)
Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice
Amit Garg et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)
Model-based drug development
R. L. Lalonde et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
Daniel C. Baumgart et al.
LANCET (2007)
Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin
Consuelo Garcia-Rodriguez et al.
NATURE BIOTECHNOLOGY (2007)
Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency
K Warnatz et al.
BLOOD (2006)
Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus
JH Yang et al.
RHEUMATOLOGY (2005)
Antibody pharmacokinetics and pharmacodynamics
ED Lobo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Inducible costimulator-positive T cells are required for allergen-induced local B-cell infiltration and antigen-specific IgE production in lung tissue
KC Beier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130
MJ Boulanger et al.
MOLECULAR CELL (2003)
Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis
WI Lee et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
General pharmacokinetic model for drugs exhibiting target-mediated drug disposition
DE Mager et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
The interleukin-13 receptor α2 chain:: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway
K Kawakami et al.
BLOOD (2001)
Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease
B Vainer et al.
CYTOKINE (2000)
A chemokine-driven positive feedback loop organizes lymphoid follicles
KM Ansel et al.
NATURE (2000)